bmiMD GLP-1 Telehealth (Semaglutide / Tirzepatide) vs Hone Health Men's Health + TRT Membership
Specs, prices, editor verdict, and who should buy which - compared side-by-side.
bmiMD GLP-1 Telehealth (Semaglutide / Tirzepatide) (mid, $289–$499/mo) vs Hone Health Men's Health + TRT Membership (mid, $45–$149/mo) - different tools for different jobs (see the per-product details below).
Compared on 0 shared specs · cross-category comparison (ai software vs diagnostic).
These are close picks. Both score in the same range. The right call depends on buyer profile - read the per-buyer recommendations below.
Who should buy which
Buyers ready for GLP-1 medical intervention who want telehealth access at meaningfully lower cost than retail Wegovy / Mounjaro, with included physician oversight and titration support.
You're unsure GLP-1 is the right intervention - start with diet + exercise + lab work first. Or you have insurance coverage for retail Wegovy / Mounjaro (run those through insurance instead).
Men 30-55 with mid-range symptomatic testosterone who want the cleanest mainstream entry into monitored TRT - no urology referral, no in-person visit, app-driven protocol management.
You want complex multi-drug protocols (Marek or Maximus go deeper), you live in a restricted-telehealth state, or you already have an in-network endocrinologist running comparable labs.